Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.82B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$827M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$721M |
| 4 |
SPDR Gold Trust
GLD
|
+$686M |
| 5 |
Coca-Cola
KO
|
+$459M |
Top Sells
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.57B |
| 2 |
Qualcomm
QCOM
|
+$708M |
| 3 |
Blackstone
BX
|
+$692M |
| 4 |
WP
Worldpay, Inc.
WP
|
+$563M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$556M |
Sector Composition
| 1 | Technology | 13.6% |
| 2 | Healthcare | 9.44% |
| 3 | Financials | 9.01% |
| 4 | Communication Services | 7.68% |
| 5 | Consumer Discretionary | 7.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3276
Opko Health
OPK
$1.2B
| $3.22M | ﹤0.01% |
1,542,898
-159,361
| -9% | -$333K |
|
3277
Fate Therapeutics
FATE
$115M
| $3.22M | ﹤0.01% |
207,466
-62,957
| -23% | -$978K |
|
3278
CorVel
CRVL
$4.26B
| $3.22M | ﹤0.01% |
127,596
-89,655
| -41% | -$2.26M |
|
|
RWW
3279
DELISTED
Invesco S&P Financials Revenue ETF
RWW
| $3.22M | ﹤0.01% |
47,209
-2,533
| -5% | -$173K |
|
3280
Quad
QUAD
$339M
| $3.22M | ﹤0.01% |
305,866
+295,867
| +2,959% | +$3.11M |
|
|
PMO
3281
Putnam Municipal Opportunities Trust
PMO
$291M
| $3.21M | ﹤0.01% |
245,858
+7,510
| +3% | +$98.1K |
|
|
NEWR
3282
DELISTED
New Relic, Inc.
NEWR
| $3.21M | ﹤0.01% |
52,268
-254,397
| -83% | -$15.6M |
|
|
TECD
3283
DELISTED
Tech Data Corp
TECD
| $3.21M | ﹤0.01% |
30,813
+5,912
| +24% | +$616K |
|
3284
Nabors Industries
NBR
$572M
| $3.2M | ﹤0.01% |
34,236
-6,577
| -16% | -$615K |
|
3285
Globus Medical
GMED
$7.66B
| $3.19M | ﹤0.01% |
62,446
-23,974
| -28% | -$1.23M |
|
3286
Nuveen Municipal High Income Opportunity Fund
NMZ
$1.23B
| $3.19M | ﹤0.01% |
223,462
+41,091
| +23% | +$587K |
|
3287
Marcus & Millichap
MMI
$1.26B
| $3.19M | ﹤0.01% |
89,837
-18,767
| -17% | -$666K |
|
3288
Forrester Research
FORR
$214M
| $3.19M | ﹤0.01% |
99,140
+49,348
| +99% | +$1.59M |
|
3289
Blue Owl Capital
OBDC
$7.07B
| $3.18M | ﹤0.01% |
+201,664
| New | +$3.18M |
|
3290
Cohen & Steers
CNS
$3.55B
| $3.18M | ﹤0.01% |
57,818
-4,398
| -7% | -$242K |
|
3291
Central Pacific Financial
CPF
$846M
| $3.18M | ﹤0.01% |
111,839
-115,930
| -51% | -$3.29M |
|
3292
TFS Financial
TFSL
$3.74B
| $3.17M | ﹤0.01% |
176,154
-2,091
| -1% | -$37.7K |
|
3293
iShares Core 80/20 Aggressive Allocation ETF
AOA
$2.6B
| $3.17M | ﹤0.01% |
57,720
+965
| +2% | +$53K |
|
3294
Chesapeake Utilities
CPK
$2.97B
| $3.16M | ﹤0.01% |
33,192
+4,032
| +14% | +$384K |
|
|
FNI
3295
DELISTED
First Trust Chindia ETF
FNI
| $3.16M | ﹤0.01% |
92,003
-21,417
| -19% | -$736K |
|
|
MRTX
3296
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $3.16M | ﹤0.01% |
40,528
+23,218
| +134% | +$1.81M |
|
3297
Fastly
FSLY
$1.32B
| $3.15M | ﹤0.01% |
131,331
+49,531
| +61% | +$1.19M |
|
3298
First Citizens BancShares
FCNCA
$24.5B
| $3.15M | ﹤0.01% |
6,677
+1,793
| +37% | +$845K |
|
|
CIR
3299
DELISTED
CIRCOR International, Inc
CIR
| $3.15M | ﹤0.01% |
83,751
-118,766
| -59% | -$4.46M |
|
3300
Cytokinetics
CYTK
$5.9B
| $3.14M | ﹤0.01% |
276,108
-10,128
| -4% | -$115K |
|